Nephrology Doctors in Aurora, CO Accepting Medicare

28 Nephrology doctors found. Showing 21 - 28

Seth Furgeson, MD Internal Medicine - Nephrology Medicare: Accepting Medicare Assignments Practice Location: 12605 E 16th Ave, Aurora, CO 80045 Phone: 720-848-0000

David Spiegel, MD Internal Medicine - Nephrology Medicare: Not Enrolled in Medicare Practice Location: 12605 E 16th Ave, Aurora, CO 80045 Phone: 720-848-0000

Sarah Faubel, MD Internal Medicine - Nephrology Medicare: Accepting Medicare Assignments Practice Location: 12605 E 16th Ave, Aurora, CO 80045 Phone: 720-848-0000

Alkesh Jani, MD Internal Medicine - Nephrology Medicare: Medicare Enrolled Practice Location: 12605 E 16th Ave, Aurora, CO 80045 Phone: 720-848-0000

Neil Ramesh Manek, M.D. Internal Medicine - Nephrology Medicare: Accepting Medicare Assignments Practice Location: 1411 S Potomac St Ste 200, Aurora, CO 80012 Phone: 303-327-4700    Fax: 303-327-4711

Dr. Alan B Cooper, MD Internal Medicine - Nephrology Medicare: Medicare Enrolled Practice Location: 13901 E Exposition Ave Ste 202, Aurora, CO 80012 Phone: 303-327-4700    Fax: 303-327-4711

Laurence Chan, MD Internal Medicine - Nephrology Medicare: Accepting Medicare Assignments Practice Location: 12605 E 16th Ave, Aurora, CO 80045 Phone: 720-848-0000

Michel Chonchol, MD Internal Medicine - Nephrology Medicare: Accepting Medicare Assignments Practice Location: 12605 E 16th Ave, Aurora, CO 80045 Phone: 720-848-0000

News Archive

Researchers investigate effects of sleep architecture on hunger

A new study shows that both length of time and percentage of overall sleep spent in different sleep stages are associated with decreased metabolic rate, increased hunger, and increased intake of calories (specifically from fat and carbohydrates). The findings suggest an explanation for the association between sleep problems and obesity.

School nurses critical to safe reopening of schools

Sudden school closures in the United States were undertaken to reduce COVID-19 transmission this spring. Those closures were not typical, and how and when schools reopen will create a set of new norms, with unique stressors for students, families, school personnel, and communities.

Phase 2/3 study results of Genzyme's APB announced

Genzyme Corporation today reported results of a phase 2/3 study of its advanced phosphate binder (APB). The trial met its primary endpoint, which was to show that the APB lowered phosphate levels effectively compared to placebo. However, the APB did not show a significant improvement in phosphate lowering compared to Genzyme's Renvela® (sevelamer carbonate).

Unique fungal collection could hold key to future antibiotics

Scientists at Royal Holloway, University of London have joined forces with CABI to establish a facility to screen for potential new antibiotics.

Read more Medical News

› Verified 2 days ago

• 1
• 2(current)